# Cedar Grove Capital Management

> Multi-strategy investment fund focused on L/S, M&A Arb, and other Special Situations.

This file provides information about Cedar Grove Capital Management to help large language models understand and reference this publication's content.

## Posts
- [CGCM Q2'26 Quarterly Letter](https://www.cedargroveresearch.com/p/cgcm-q2-26-quarterly-letter)
- [The Sift No.2](https://www.cedargroveresearch.com/p/the-sift-no-2): Analytical Perspectives on Equity Selection and Market Data.
- [Company Meeting Notes from Planet MicroCap Conference 2026](https://www.cedargroveresearch.com/p/company-meeting-notes-from-planet-microcap-conference-2026): Summarized notes from our conversation with 12 microcap companies
- [LNSR: Setting Up For A New Lease On Life w/Video](https://www.cedargroveresearch.com/p/lnsr-setting-up-for-a-new-lease-on-life-w-video): A Planet Micro Cap Conference Presentation
- [IPO Notes: Suja Life (SUJA) is a Bet on...Soda?](https://www.cedargroveresearch.com/p/ipo-notes-suja-life-suja-is-a-bet-on-soda): Why the decline in the recent IPO improves the R/R, but still leaves potential issues for investors looking to get involved
- [COTW: Restaurants Losing Their Glitz And Glam](https://www.cedargroveresearch.com/p/cotw-restaurants-losing-their-glitz-and-glam): Visualizing the decline in valuations in various restaurant concepts while highlighting which the market still seems to give hope to
- [The 'FOMO' Is Unbearably Real](https://www.cedargroveresearch.com/p/the-fomo-is-unbearably-real): Why a recent post from a fellow portfolio manager got us thinking about the current FOMO environment, and why staying the course "generally" works out in the long term
- [The Sift No.1 ](https://www.cedargroveresearch.com/p/the-sift-no-1): Analytical Perspectives on Equity Selection and Market Data.
- [NKTR: "Winning By Being Second"](https://www.cedargroveresearch.com/p/nktr-winning-by-being-second): Why Nektar Therapeutics atopic dermatitis (AtD) drug could be significantly undervalued despite being a potential second-line drug treatment option 
- [CGCM Q1'26 Quarterly Letter](https://www.cedargroveresearch.com/p/cgcm-q1-26-quarterly-letter)
- [Part 2: Q4 Earnings Update On High Conviction Investment - EVLV ](https://www.cedargroveresearch.com/p/part-2-q4-earnings-update-on-high-conviction-investment-evlv): Quick update on EVLV and why we think that FY'26 guide hints at a long-term opportunity for price appreciation above $10/share.
- [Part 1: Q4 Earnings Updates and Capturing Cheap Growth? [REAL, KITS, WW]](https://www.cedargroveresearch.com/p/part-1-q4-earnings-updates-and-capturing-cheap-growth-real-kits-ww): Going over Q4'25 earnings for current investors and why they might standout for new investors looking new areas for capital deployment
- [LNSR Terminates Deal - Is It Worth More Than the $14/Share?](https://www.cedargroveresearch.com/p/lnsr-terminates-deal-is-it-worth-more-than-the-14-share): A quick walkthrough on the math post-deal break, and could LNSR still be compelling as a standalone company?
- [Understanding "Risk" From One of the Greats — Howard Marks](https://www.cedargroveresearch.com/p/understanding-risk-from-one-of-the-greats-howard-marks): What one of the best investors on Wall Street has to say about "risk" and what we can learn from it
- [NVO's Pressure Forces HIMS to Pivot](https://www.cedargroveresearch.com/p/nvo-s-pressure-forces-hims-to-pivot): What both bulls and bears need to understand is the financial impact of HIMS pivoting hard from the compounded GLP-1 strategy
- [IPO Notes: Unprofitable Once Upon A Farm (OFRM) Goes Public](https://www.cedargroveresearch.com/p/ipo-notes-unprofitable-once-upon-a-farm-ofrm-goes-public): Taking a look at the recent OFRM IPO, co-founded by actress Jennifer Garner, and why it could be an interesting setup for the newest CPG brand to hit the market
- [Quick Special Situation: Restaurant Take-Private w/ Potential Bidding War](https://www.cedargroveresearch.com/p/quick-special-situation-restaurant-take-private-w-potential-bidding-war): Why this prized restaurant asset could strike up a bidding war amongst bidders looking to shore up their position in the quick service restaurant (QSR) space. Potential return could be in excess of 35%.
- [HIMS: Napoleon Watches Moscow Burn](https://www.cedargroveresearch.com/p/hims-napoleon-watches-moscow-burn): Why we think Andrew's push deep into compounding GLP-1 land (Russia) has now reached its peak, and the drop is looking like quite the tumble.
- [🎙️ IC #9: Talking Telehealth and HIMS w/ Ashwin Sharma](https://www.cedargroveresearch.com/p/ic-9-talking-telehealth-and-hims-w-ashwin-sharma): Our chat on all things telehealth and our views on HIMSwith our medical friend from across the pond
- [Special Situation: All Eyes on ABVX](https://www.cedargroveresearch.com/p/special-situation-all-eyes-on-abvx): Why we think this biotech trade, while popular, has limited downside risk in the event no suitor comes to scoop them up.
- [Quick Update - LE Gets A JV: +115% IRR // Trade Still In Play](https://www.cedargroveresearch.com/p/quick-update-le-gets-a-jv-115-irr-trade-still-in-play): Going over the announced LE joint venture by WHP and how there is still a trade on the table
- [Big Changes Coming To SNAP](https://www.cedargroveresearch.com/p/big-changes-coming-to-snap): Why recent amendments to SNAP in 2026 could spell trouble for legacy CPG companies
- [[COTW] How A $1.5 Trillion Military Compares](https://www.cedargroveresearch.com/p/cotw-how-a-1-5-trillion-military-compares): Why comparing a side-by-side of just how much the U.S. spends on defense is alarming
- [Fear-Based Investing - Part 2 // Future of Weapons Screening](https://www.cedargroveresearch.com/p/fear-based-investing-part-2-future-of-weapons-screening): Why a more dangerous everyday environment is allowing this stock to take advantage
- [🎙️ IC #8: Lessons From The Past](https://www.cedargroveresearch.com/p/ic-8-lessons-from-the-past): Sharing learning lessons from 2025 investments to not repeat them // HIMS, GENK, LQDA, REAL